Attrition and delays before treatment initiation among patients with MDR-TB in China (2006-13): Magnitude and risk factors.

Attrition and delays before treatment initiation among patients with MDR-TB in China (2006-13): Magnitude and risk factors.

<h4>Background</h4>China's national tuberculosis programme does not have cohort wise information regarding attrition and delays in the multidrug resistant tuberculosis (MDR-TB) diagnosis and treatment pathway.<h4>Objective</h4>Under the Global Fund programmatic managemen...

Full description

Bibliographic Details
Main Authors:	Caihong Xu, Renzhong Li, Hemant Deepak Shewade, Kathiresan Jeyashree, Yunzhou Ruan, Canyou Zhang, Lixia Wang, Hui Zhang
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2019-01-01
Series:	PLoS ONE
Online Access:	https://doi.org/10.1371/journal.pone.0214943

Similar Items

Low pre-diagnosis attrition but high pre-treatment attrition among patients with MDR-TB: An operational research from Chennai, India
by: Hemant Deepak Shewade, et al.
Published: (2019-04-01)

High pre-diagnosis attrition among patients with presumptive MDR-TB: an operational research from Bhopal district, India
by: Hemant Deepak Shewade, et al.
Published: (2017-04-01)

Erratum to: High pre-diagnosis attrition among patients with presumptive MDR-TB: an operational research from Bhopal district, India
by: Hemant Deepak Shewade, et al.
Published: (2017-04-01)

Community-based MDR-TB care project improves treatment initiation in patients diagnosed with MDR-TB in Myanmar.
by: Pyae Phyo Wai, et al.
Published: (2018-01-01)

Training medical undergraduates in the core disciplines of community medicine through community postings – an experience from India
by: Hemant Deepak Shewade, et al.
Published: (2016-08-01)

Development and psychometric testing of an abridged version of Dundee Ready Educational Environment Measure (DREEM)
by: Kathiresan Jeyashree, et al.
Published: (2018-04-01)

Effect of glycemic control and type of diabetes treatment on unsuccessful TB treatment outcomes among people with TB-Diabetes: A systematic review.
by: Hemant Deepak Shewade, et al.
Published: (2017-01-01)

Comparing yield and relative costs of WHO TB screening algorithms in selected risk groups among people aged 65 years and over in China, 2013.
by: Canyou Zhang, et al.
Published: (2017-01-01)

MDR TB Transmission, Singapore
by: Cynthia B.E. Chee, et al.
Published: (2013-07-01)

Defaulting rate of MDR-TB patients in the MDR unit Limpopo Province
by: Chauke, Lucky Themba
Published: (2016)

Molecular Diagnosis of TB and MDR-TB in HIV-Coinfection in Nigeria
by: Dinic, Lana
Published: (2013)

Geospatial analysis and identification of space-time clusters of MDR-TB in South Africa, 2006-2012
by: M. Mudau, et al.
Published: (2014-04-01)

Relationship Between TB Treatment Phase and Knowledge of MDR TB with TB Patient’s Compliance
by: I Dewa Ayu Made Made Yuni
Published: (2017-03-01)

Patient and health system delays before registration among migrant patients with tuberculosis who were transferred out in China
by: Tao Li, et al.
Published: (2018-10-01)

Management of MDR-TB at the University Hospital of Kinshasa
by: J.M.N. Kayembe, et al.
Published: (2014-04-01)

Heightened vulnerability to MDR-TB epidemics after controlling drug-susceptible TB.
by: Jason D Bishai, et al.
Published: (2010-09-01)

Mathematical Model of MDR-TB and XDR-TB with Isolation and Lost to Follow-Up
by: F. B. Agusto, et al.
Published: (2015-01-01)

The study of TB and MDR-TB in Kwa-Thema township from 2000-2004
by: Rembuluwani, Azwinaki
Published: (2008)

Prevalence and Factors Associated with Multidrug-Resistant Tuberculosis (MDR-TB) among Presumptive MDR-TB Patients in Tigray Region, Northern Ethiopia
by: Kibriti Mehari, et al.
Published: (2019-01-01)

Patients with MDR-TB on domiciliary care in programmatic settings in Myanmar: Effect of a support package on preventing early deaths.
by: Pyae Phyo Wai, et al.
Published: (2017-01-01)

Public reasoning in MSF MDR-TB programme in Khayelitsha
by: Mhlantla, Thandeka Thokozile
Published: (2015)

Why has MDR-TB prevalence increased in Iran?
by: Mohsen Heidary, et al.
Published: (2016-12-01)

Predictors of Multidrug-Resistant Tuberculosis (MDR-TB) in Sudan
by: Monadil H. Ali, et al.
Published: (2019-07-01)

Syntéza salicylanilidových esterů působících na MDR-TB
by: Vosátka, Rudolf
Published: (2013)

Molecular characterization of multidrug-resistant Mycobacterium tuberculosis (MDR-TB) isolates identifies local transmission of infection in Kuwait, a country with a low incidence of TB and MDR-TB
by: Noura M. Al-Mutairi, et al.
Published: (2019-12-01)

Analysis of multi drug resistant tuberculosis (MDR-TB) financial protection policy: MDR-TB health insurance schemes, in Chhattisgarh state, India
by: Debashish Kundu, et al.
Published: (2018-01-01)

Malnutrition is Associated with Delayed Sputum Culture Conversion Among Patients Treated for MDR-TB
by: Bade AB, et al.
Published: (2021-04-01)

Correction to: Molecular characterization of multidrug-resistant Mycobacterium tuberculosis (MDR-TB) isolates identifies local transmission of infection in Kuwait, a country with a low incidence of TB and MDR-TB
by: Noura M. Al-Mutairi, et al.
Published: (2020-04-01)

The endTB observational study protocol: treatment of MDR-TB with bedaquiline or delamanid containing regimens
by: Uzma Khan, et al.
Published: (2019-08-01)

The Role of Adherence and Retreatment in De Novo Emergence of MDR-TB.
by: Dominique Cadosch, et al.
Published: (2016-03-01)

Multistate Outbreak of MDR TB Identified by Genotype Cluster Investigation
by: Pennan M. Barry, et al.
Published: (2012-01-01)

Six-Month Response to Delamanid Treatment in MDR TB Patients
by: Cathy Hewison, et al.
Published: (2017-10-01)

Adverse events in healthy individuals and MDR-TB contacts treated with anti-tuberculosis drugs potentially effective for preventing development of MDR-TB: a systematic review.
by: Miranda W Langendam, et al.
Published: (2013-01-01)

HUBUNGAN DUKUNGAN KELUARGA DENGAN EFIKASI DIRI PENDERITA TUBERCULOSIS MULTIDRUG RESISTANT (TB-MDR) DI POLI TB-MDR RSUD IBNU SINA GRESIK
by: Mar'atul Hasanah, et al.
Published: (2018-12-01)

Collaborative public–private initiatives targeting multidrug-resistant tuberculosis (MDR-TB) supported by the Lilly MDR-TB Partnership: experiences in 2012–2016
by: Shelby PW, et al.
Published: (2017-06-01)

Cost-effectiveness of new MDR-TB regimens: study protocol for the TB-PRACTECAL economic evaluation substudy
by: Sedona Sweeney, et al.
Published: (2020-10-01)

Prospective evaluation of simply modified MODS assay: an effective tool for TB diagnosis and detection of MDR-TB
by: Chaiyasirinroje B, et al.
Published: (2012-05-01)

Magnitude of malnutrition amongst hospitalized TB patients
by: Rohit Sarin, et al.
Published: (2011-01-01)

Risk factors for poor treatment outcomes in patients with MDR-TB and XDR-TB in China: retrospective multi-center investigation.
by: Shenjie Tang, et al.
Published: (2013-01-01)

Low-dose amikacin in the treatment of Multidrug-resistant Tuberculosis (MDR-TB)
by: Natasha F. Sabur, et al.
Published: (2021-03-01)